Use
Diabetes mellitus, type 2:?To improve glycemic control in adults with type 2 diabetes mellitus as an adjunct to diet and exercise
Medication Safety Issues
Sound-alike/look-alike issues:
Prandin may be confused with Avandia
Repaglinide may be confused with rasagiline
Storage/Stability
Store at 20?C to 25?C (68?F to 77?F). Protect from moisture.
Adverse Reactions
>10%:
Central nervous system: Headache (9% to 11%)
Endocrine & metabolic: Hypoglycemia (16% to 31%)
Respiratory: Upper respiratory tract infection (10% to 16%)
1% to 10%:
Cardiovascular: Ischemia (4%), chest pain (2% to 3%)
Gastrointestinal: Diarrhea (4% to 5%), constipation (2% to 3%)
Genitourinary: Urinary tract infection (2% to 3%)
Hypersensitivity: Hypersensitivity reaction (1% to 2%)
Neuromuscular & skeletal: Back pain (5% to 6%), arthralgia (3% to 6%)
Respiratory: Sinusitis (3% to 6%), bronchitis (2% to 6%)
<1%, postmarketing, and/or case reports: Alopecia, anaphylactoid reaction, blurred vision (transient), cardiac arrhythmia, ECG abnormality, hemolytic anemia, hepatic insufficiency (severe), hepatitis, hypertension, increased liver enzymes, jaundice, leukopenia, myocardial infarction, palpitations, pancreatitis, Stevens-Johnson syndrome, thrombocytopenia, visual disturbance (transient)
Reviews
There are no reviews yet